Artificial Intelligence
Episode 1: AI That Actually Gets Used — A Startup’s Take on Pharma Innovation
Guest: Inderpreet Kambo, CEO of Improzo
Host: Jane Urban, Chief Data & Analytics Officer, Improzo
Date : August 20, 2025
Time : 35 Min
About the Episode
You’re about to enter a new dimension—where the boundaries of life sciences, data, and technology blur, and AI reshapes what’s possible. Welcome to The Improzone, powered by Improzo.
In this launch episode, Jane Urban sits down with Improzo’s CEO and co-founder, Inderpreet Kambo, to talk about what happens when you stop building dashboards—and start building decisions.
Drawing from his career across ZS, IQVIA, and Takeda, Inder shares why so many AI programs in pharma fall short of real-world impact, and how Improzo was designed to fix the last mile: where insights need to become action.
Highlights from the episode:
- How “AI slideware” became the industry norm—and why that’s a problem
- Why Improzo is built directly into tools like Veeva, Salesforce, and Snowflake
- What it means to deploy modular AI agents that actually do work
- How to build trust in AI without slowing down innovation
- When clients ask for more agents, you know it’s working
One quote to remember:
“Insight doesn’t equal impact. You have to meet users where they are—and build AI that fits how they actually work.”
From KOL insights that move from PDF to action in hours, to AI copilots that operate inside the existing pharma workflow, this episode kicks off the series with a clear message: execution is everything.
This has been The Improzone: improving life, empowering customers. Follow us and stay tuned for what’s next.
About the Authors
Jane Urban
Chief Data & Analytics Officer
Inderpreet Kambo
Cofounder and Chief Executive Officer
